Kralicek Andrew V, Radjainia Mazdak, Mohamad Ali Nazratul A B, Carraher Colm, Newcomb Richard D, Mitra Alok K
The New Zealand Institute for Plant & Food Research Limited, Private Bag 92169, Auckland, New Zealand.
Protein Expr Purif. 2011 Nov;80(1):117-24. doi: 10.1016/j.pep.2011.06.006. Epub 2011 Jun 22.
N-terminal fusion tags that enhance translation initiation or protein solubility are often used to facilitate protein overexpression. As the optimal tag for a given target protein cannot be predicted a priori, valuable time can be lost in cloning and manipulating the corresponding gene to generate different fusion constructs for expression analysis. We have developed a cell-free strategy that consolidates these steps, enabling the utility of a panel of nine fusion-tags to be determined within one to two days. This approach exploits the fact that PCR-amplified DNA can be used as a template for cell-free protein synthesis. Overlap/extension PCR using the TEV protease site as the overlap region allows the fusion of different T7 promoter (T7p)-tag-TEV DNA fragments with a TEV-gene-T7 terminator (T7ter) fragment. For tag sequences where the TEV site is not compatible, a short C₃G₃ repeat (CGr) sequence can be used as the overlap region. The resulting T7p-tag-TEV-gene-T7ter constructs are then used as templates for PCR-directed cell-free protein synthesis to identify which tag-TEV-gene fusion protein produces the highest amount of soluble protein. We have successfully applied this approach to the overexpression of the Adiponectin hypervariable domain (AHD). Five of the nine N-terminal fusion tags tested enabled the synthesis of soluble recombinant protein. The best of these was the Peptidyl-prolylcis-trans isomerise B (PpiB) fusion tag which produces 1mg/ml amounts of soluble fusion protein. PpiB is an example of a new class of fusion tag known as the "stress-responsive proteins". Our results suggest that this cell-free fusion-tag expression screen facilitates the rapid identification of suitable fusion-tags that overcome issues such as poor expression and insolubility, often encountered using conventional approaches.
用于增强翻译起始或蛋白质溶解性的N端融合标签常被用于促进蛋白质的过表达。由于无法预先预测给定目标蛋白的最佳标签,在克隆和操作相应基因以生成不同的融合构建体用于表达分析时,可能会浪费宝贵的时间。我们开发了一种无细胞策略,将这些步骤整合在一起,能够在一到两天内确定一组九个融合标签的效用。这种方法利用了PCR扩增的DNA可作为无细胞蛋白质合成模板这一事实。使用TEV蛋白酶切割位点作为重叠区域的重叠/延伸PCR,可使不同的T7启动子(T7p)-标签-TEV DNA片段与TEV-基因-T7终止子(T7ter)片段融合。对于TEV位点不兼容的标签序列,短的C₃G₃重复(CGr)序列可作为重叠区域。然后将所得的T7p-标签-TEV-基因-T7ter构建体用作PCR导向的无细胞蛋白质合成模板,以确定哪种标签-TEV-基因融合蛋白能产生最高量的可溶性蛋白。我们已成功将此方法应用于脂联素高变区(AHD)的过表达。测试的九个N端融合标签中有五个能够合成可溶性重组蛋白。其中最佳的是肽基脯氨酰顺反异构酶B(PpiB)融合标签,它能产生1mg/ml的可溶性融合蛋白。PpiB是一类被称为“应激反应蛋白”的新型融合标签的一个例子。我们的结果表明,这种无细胞融合标签表达筛选有助于快速鉴定合适的融合标签,并克服传统方法中经常遇到的诸如表达不佳和不溶性等问题。